Login to Your Account

Other News To Note

Friday, June 1, 2012
• Medigene AG, of Martinsried, Germany, said genital warts treatment Veregen obtained market approval in Serbia. The drug will be launched there in the second half of this year.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription